I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

As populations are aging and the number of elderly individuals is exponentially increasing, there are a growing number of people in need of long-term care. Therefore, the need for evaluation, assessment, and updating knowledge on frequency and control of chronic disabling diseases becomes more important. In addition, as countries in developing societies confront the effects of change in the burden and epidemiological transition of chronic noncommunicable diseases, there will be an increased need for up-to-date assessment of nonfatal health outcomes and exploration of the implications of growing number of individuals with chronic diseases.\[[@ref1]\] Moreover, as the expense of health-care delivery in Nigeria rises toward unsustainable levels, there is a need for cost justification in which the prevalence, morbidity, and disability of the diseases we manage are becoming critical to the continued allocation of available meager resources toward neurological care. This is so because the outcome of huge financial investments in cardiovascular diseases in developed societies in the past has yielded significant benefits for such diseases, dramatically increasing overall health and survival.\[[@ref1]\]

Although mortality is the usual primary outcome measure in many research studies, the cost and societal impact of diseases are largely determined by the disability they cause; this is particularly true of neurological disorders since the years lost to disability from neurological and musculoskeletal disorders are greater than that of all other categories of diseases.\[[@ref2][@ref3]\] After comprehensive review of the nationwide and world literature, we chose for discussion the most prevalent and commonly managed neurological diseases in the region, focusing on those prevalence and incidence estimates we considered the most reliable. Using this method, stroke, compressive myelopathies, epilepsy, movement disorders, and headache emerged as the most common disorders and are highlighted below. We excluded many other disorders that are not as common and disorders with mixed etiologies to be as conservative as possible, despite the fact that these diseases were managed in our neurology unit.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

This was a retrospective study conducted in the neurology unit of Usmanu Danfodiyo University Teaching Hospital Sokoto (UDUTHS) over the period of 5 years (between January 2010 and December 2014). Relevant data were extracted from patients\' case folders; data were validated using Microsoft Excel. Relevant data were analyzed. Adjustment to correct for potential biases such as multiple admissions and secondary diagnosis using a covariate on admission data was made to correct for systematic error. Information obtained was analyzed for frequency and distribution. Analysis of data was carried out using the "Statistical Package for the Social Sciences" (SPSS) program for Windows version 23.0 (SPSS Inc., Chicago, IL, USA). Mean and standard deviation (SD) were used to describe quantitative variables. Bivariate analysis was carried out using Pearson\'s Chi-square or Fisher\'s exact test for categorical variables. Student\'s *t*-test was used to compare the means of continuous variables.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

There were a total of 2537 cases of neurological disorders managed in the unit during the study period. Females accounted for 52.7% and males were 47.3%, with a female-to-male ratio of 1.1:1 \[[Figure 1](#F1){ref-type="fig"}\]. The mean age was 44.9 years (SD ± 16.7), with an age range of 15--99 years. The common neurological disorders were stroke (21.3%), spinal cord compression syndromes (20.9%), and epilepsy (17.3%) \[[Table 1](#T1){ref-type="table"}\]. The highest number of cases of neurological disorder occurred within the age group of 45--54 years \[[Table 2](#T2){ref-type="table"}\]. Correlation of Age and sex showed predominance of neurological diseases among young females \[[Figure 2](#F2){ref-type="fig"}\]. Distribution of neurological disorders by sex, showed predominance of neurological diseases among females \[[Table 3](#T3){ref-type="table"}\], the role of sex was further evaluated by sex and age correlation \[[Table 4](#T4){ref-type="table"}\].

![Sex distribution of neurological diseases among patients](AAM-18-55-g001){#F1}

###### 

Frequency of neurological disorders

  Diagnosis                                           Frequency (%)
  --------------------------------------------------- ---------------
  Stroke                                              540 (21.3)
  Cord compression syndrome                           529 (20.8)
  Epilepsy                                            438 (17.3)
  Parkinsonian syndromes                              225 (8.9)
  Headaches                                           181 (7.1)
  Bacterial meningitis                                131 (5.2)
  Peripheral neuropathy                               107 (4.2)
  Cranial neuropathy                                  87 (3.4)
  Encephalopathies                                    54 (2.1)
  Dementia                                            50 (2)
  Muscular dystrophy                                  44 (1.7)
  Myasthenia gravis                                   33 (1.3)
  Intracranial tumors                                 28 (1.1)
  Noncompressive myelopathies                         22 (0.9)
  Other movement disorders                            19 (0.7)
  Motor neuron disease                                13 (0.5)
  Chronic inflammatory demyelinating polyneuropathy   7 (0.3)
  Hematoma                                            8 (0.3)
  Cerebral palsy                                      6 (0.2)
  Hydrocephalus                                       6 (0.2)
  Congenital anomalies                                5 (0.2)
  Cerebella ataxia                                    4 (0.2)
  Total                                               2537 (100)

###### 

Age distribution of neurological disorder

  Age group   Frequency (%)
  ----------- ---------------
  15-24       345 (13.6)
  25-34       371 (14.6)
  35-44       405 (15.9)
  45-54       673 (26.6)
  55-64       425 (16.8)
  65-74       195 (7.7)
  75-84       88 (3.5)
  85-94       35 (1.3)
  Total       2537 (100)

![Age and sex distribution of neurological diseases among patients](AAM-18-55-g002){#F2}

###### 

Distribution of neurological disorder by sex

  Diagnosis                                           Female   Male   Total
  --------------------------------------------------- -------- ------ -------
  Stroke                                              269      271    540
  Cord compression syndromes                          253      276    529
  Epilepsy                                            356      82     438
  Parkinsonian syndromes                              8        217    225
  Headache                                            151      30     181
  Bacterial meningitis                                76       55     131
  Peripheral neuropathies                             29       78     107
  Cranial neuropathy                                  50       37     87
  Encephalopathies                                    32       22     54
  Dementia                                            29       21     50
  Muscular dystrophies                                3        41     44
  Myasthenia gravis                                   0        33     33
  Intracranial tumors                                 21       7      28
  Noncompressive myelopathies                         20       2      22
  Other movement disorders                            16       3      19
  Motor neuron diseases                               0        13     13
  Subdural hematoma                                   2        6      8
  Chronic inflammatory demyelinating polyneuropathy   7        0      7
  Cerebral palsy                                      6        0      6
  Hydrocephalus                                       6        0      6
  Congenital anomalies                                0        5      5
  Cerebella ataxia                                    4        0      4
  Total                                               1339     1198   2537

###### 

Cross tabulation by age and sex among neurological patients

  Age group   Female   Male   Total
  ----------- -------- ------ -------
  15-24       342      3      345
  25-34       360      11     371
  35-44       321      84     405
  45-54       136      537    673
  55-64       76       349    425
  65-74       65       130    195
  75-84       33       55     88
  85-94       6        29     35
  Total       1339     1198   2537

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

The highest frequency of neurological disorders observed in the 45--54 years\' age group was lower than the frequency found in the 50--60 years\' age group reported in a study in Ghana,\[[@ref4]\] but the mean age of 44.9 years in this study correlated well with the study in Cameroon.\[[@ref5]\]

Stroke {#sec2-1}
------

In this study, stroke is rated as the most common neurological disorder which corroborated findings of a study from the southern part of the country\[[@ref6]\] and earlier study in this region by Owolabi *et al*.\[[@ref7]\] The mean age of 56.85 years, SD ± 14.40, is similar to the mean age of 58 years reported by Divyant and Amit\[[@ref8]\] in a study on clinical profile and risk factors among 140 stroke patients in a tertiary care hospital in Bareilly; it also corresponded well with the mean age of 57 years reported by Manorenj *et al*.\[[@ref9]\] and findings in other studies in developed\[[@ref10]\] and developing countries.\[[@ref11][@ref12]\] Therefore, this study supported previous hospital- and community-based studies that reported the incidence and prevalence of stroke among both blacks and nonblacks. More importantly, this study found trends toward increasing stroke incidence among relatively young individuals, a finding that is of great public health significance.

Epilepsy {#sec2-2}
--------

The female preponderance was observed in an earlier study from southeast Nigeria.\[[@ref10]\] The average age of patients was 35.8 years with SD ± 9.6 and an age range of 24--72 years. This figure did not correlate well with findings by Kora *et al*. among patients with posterior circulation stroke in a tertiary care center in southern India.\[[@ref11]\] The study also revealed that the peak age prevalence occurred within the age group of 30--39 years which constituted 58.2%, followed by the age group of 20--29 years which constituted 22.6% of all cases. Finding in this study supported report of International League Against Epilepsy Commission on epidemiology, that epilepsy is a common neurological disorder affecting about 65 million people in the world,\[[@ref13]\] and approximately 80% of cases occur in developing countries with little or no access to medical facilities or treatment.\[[@ref14]\] The burden of and the global socioeconomic costs afforded by epilepsy are enormous, and its deleterious effect on psychological, cognitive, and social functioning on those who are affected is often substantial and devastating.\[[@ref15]\]

Compressive myelopathies {#sec2-3}
------------------------

The male preponderance of tuberculosis of the spin in this study substantiated differential sex hospital attendance pattern in the region of the study, as women often require permission of their husbands to access health care in a hospital environment, as alluded to in some other previous studies.\[[@ref16][@ref17][@ref18][@ref19][@ref20]\] Pott\'s disease is one of the major causes of compressive myelopathies in developing countries; the disease is chronic, debilitating, and associated with long-term sequelae, such as pressure sore, deep venous thrombosis, and risk of pulmonary embolism.\[[@ref21]\] The second common compressive myelopathy in this study is cervical spondylosis. The mean age of affected people in this study was 52 years, which correlated well with earlier studies by Pallis *et al*. who found that cervical spondylosis was a disease of the elderly affecting mostly those over 50 years.\[[@ref22]\] In a related development, Ahmed *et al*. found that the maximum number of cases (60%) of cervical spondylosis among patients in Bangladesh was in the age group of above 50 years.\[[@ref23]\]

Movement disorders {#sec2-4}
------------------

The mean age of 51.5 years among patients with secondary parkinsonism in our study was similar to 51.4 years of secondary parkinsonism reported by Femi *et al*.\[[@ref24]\] in an earlier study in this region. It is also similar to what was reported in southwestern Nigeria by Osuntokun and Bademosi.\[[@ref25]\] In addition, the mean age of our patients corroborated what was reported in other nations.\[[@ref26][@ref27][@ref28]\] Male preponderance in our study was reported in other studies though the gender proportion in our study is much higher than earlier studies in the country. This may be accounted for by methodological differences between the studies; our study population was all patients with movement disorders.

Headaches {#sec2-5}
---------

The female preponderance of headache found in our study is similar to earlier studies that cut across cultures and geographical locations,\[[@ref29][@ref30][@ref31][@ref32][@ref33]\] including a cohort study in our center.\[[@ref34]\] Possible mechanisms mentioned include hormonal influence and factors related to health-seeking behavior of female gender, particularly for headache disorders.\[[@ref35]\]

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

This study revealed that stroke and spinal cord compression syndrome are the most common neurological disorders in our center. It also showed that individuals within their productive age (50--54 years) are more commonly affected. Therefore, given the present state of constrained resources and competing priorities, coordinated efforts at the individual, institutional, organizational, local, state, and federal government levels are essential to encourage prioritization, funding, and implementation for the above initiatives. Subspecialty organizations and individual neurologists and neuroscientists must work together to coordinate their advocacy efforts. It is important to note that the very future of the neurological sciences and the patients we manage is now at stake, and the welfare of generations yet to come hangs upon the success of our efforts. This study serves as a key component to the policy-makers and planners to plan well in establishing policies and resource allocation, as well as supplying of adequate diagnostic facilities.

Recommendations {#sec2-6}
---------------

Given the resource-limited setting in developing countries and the cost of brain disorders, which are frequently chronic and sometimes relapsing, greater emphasis needs to be placed on early detection, effective treatment, and early preventionIn view of the relevance of determining the prevalence of disorders of the brain, there is need for concerted effort by all stakeholders toward advocacy, through the provision of education, publications, consultation, and evaluation services. This is particularly critical as some of these vulnerable patients are unable to advocate for themselvesPrivate--public partnerships should be encouraged to promote novel drug development and to rapidly bring treatments to patients with brain disordersEfforts to remove hurdles to research must be supported at governmental level, such as removing inappropriate regulations and bottlenecks within the system that would facilitate implementing faster and simpler processes for approval and governance of translational research.
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